Arnica Montana 30C (arnica montana) NDC 68466-1041

NDC codes

FDA NDC Directory

Product NDC (as listed)68466-1041Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68466-1041Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68466-1041-2	68466104102	1 BOTTLE, GLASS in 1 PACKAGE (68466-1041-2) / 250 TABLET in 1 BOTTLE, GLASSMarketed from Jan 1, 2006

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Arnica Montana 30C
Generic name (nonproprietary): arnica montana
Active ingredients: Arnica montana — 30 [hp_C]/1
Dosage form: Tablet
Route: Sublingual, Sublingual, Sublingual
Labeler: Schwabe Mexico, S.A. de C.V.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2006
Marketing end: Mar 31, 2027
Identifiers: Product ID 68466-1041_cd693332-cf97-4139-a5df-0c7164f94730SPL ID cd693332-cf97-4139-a5df-0c7164f94730SPL set ID a4743dcd-dd86-4d56-9d61-3dfb60598076UNII O80TY208ZW

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Sublingual, Sublingual, Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468466104102 followed by a unit qualifier and the quantity

Package 68466-1041-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 20, 2022.

Indications (excerpt from the label)

Indications & Usage Temporarily relieves minor muscle or joint aches and pains from strains, sprains, bruises, backache, over extertion.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)